Irish chemical industry news

• Arkema to Acquire Arc Building Products in Ireland

  13 December 2023

  SpecialtiesPolymers

  

  The acquisition will enhance Arkema's market position in Ireland, expanding its product range and local production. The deal is set to close in Q1 2024.
• Irving Oil Reviews Whitegate Refinery's Future

  7 June 2023

  Refinery

  

  The company is considering options including a sale of key assets. The review, driven by industry challenges, could impact Ireland's energy security. The government is monitoring the situation.
• Dexcom to Build First European Plant in Galway, Ireland

  5 May 2023

  Pharma

  

  The new facility in Galway will create up to 1,000 high-skilled jobs, supported by the Irish Government, and focus on automated, green technologies for continuous glucose monitoring.
• MSD Ireland Expands Carlow Site

  23 August 2022

  Pharma

  

  Over 100 new jobs will be created as a new facility for next-gen oncology biologics begins construction, operational by 2025, adding to the existing 530 staff and 700 construction roles.
• Abbott Invests €430 Million in Irish Diabetes Operations

  12 August 2022

  Pharma

  

  New greenfield facility in Kilkenny and expansion in Donegal will create 1,000 jobs, supported by the Irish Government through IDA Ireland.

• WuXi Vaccines to Invest $240M in New Ireland Facility

  22 November 2019

  CDMOPharma

  

  The new facility in Dundalk will create 200 jobs, produce vaccines for a global pharma, and enhance Ireland's life sciences ecosystem, pending planning approval.
• Almac Group Adopts Continuous Flow Technology

  8 January 2019

  CDMOPharma

  

  The company expands its API services with continuous flow technology, enhancing product quality, process safety, and efficiency. A 4-year strategy focuses on advanced synthesis methods.
• Praxair to Sell European Assets to Taiyo Nippon Sanso

  5 July 2018

  

  The sale, worth 5 billion euros, includes Praxair's industrial gases businesses in 12 countries and 2,500 employees. The deal is contingent on the Praxair-Linde merger and regulatory approvals.
• Takeda to Build New Production Facility in Ireland

  31 May 2017

  CDMOPharma

  

  The new facility will expand Takeda's Grange Castle site, creating 40 jobs and producing NINLARO® for global markets. Construction starts June 2017, with operations beginning in late 2018.
• Boliden Expands Tara Mine

  11 January 2017

  Base chemistry

  

  New mineralisation at Tara zinc mine identified. Tailings dam expansion and exploration drift approved, extending mine life to 2026. Investment totals EUR 44m, pending permits.
• Takeda to Invest €40M in New Dublin Facility

  5 December 2016

  CDMOPharma

  

  The €40M investment will expand the Grange Castle site, creating 40 jobs and producing the oncology product NINLARO™. Supported by IDA Ireland, it highlights confidence in Ireland's pharma sector.
• Evonik Invests in Vivasure Medical

  20 September 2016

  

  Evonik's investment supports Vivasure's bioabsorbable arteriotomy closure device, leveraging Evonik's polymer expertise to enhance minimally invasive procedures and patient outcomes.
• Jazz Pharmaceuticals Opens New Facility in Roscommon

  2 August 2016

  CDMOPharma

  

  The new facility, supported by IDA Ireland, represents a €50 million investment and will employ up to 50 people. It has received FDA and Irish regulatory approval.
• GSK Opens Two New Facilities After €12m Cork Investment

  26 February 2016

  CDMOPharma

  

  The new Kilo Scale Facility and Technical Development Laboratory will enhance manufacturing of oncology medicines and improve existing products, reinforcing the Cork site's technical capabilities.
• BASF Expands Cork Manufacturing Plant

  12 September 2014

  

  The Cork site will boost LIX® solvent extractant production by Q1 2015 to meet rising demand. New labs in Johannesburg, Shanghai, and Moscow enhance technical service and customer proximity.
• Jazz Pharmaceuticals Begins Construction on New Facility in Ireland

  10 February 2014

  CDMOPharma

  

  The new facility in Roscommon will cost $60-$68M, create 160 construction jobs, and 50 permanent jobs. Supported by IDA Ireland, it marks Jazz's first manufacturing site. Completion expected in 2016.
• UC RUSAL to Convert Aughinish Refinery to Gas

  28 March 2013

  Base chemistry

  

  The Aughinish refinery in Ireland will replace oil-fired boilers with gas-powered steam generators by 2014, enhancing economic and environmental performance amid a broader modernization effort.
• GSK to Invest €250M in Irish Facility

  29 March 2007

  SpecialtiesCDMOPharma

  

  The investment will support production of lapatinib for advanced breast cancer treatment, creating up to 150 new jobs at the Currabinny site, established in 1975 and employing over 600 people.